CRISPR/Cas9 genome editing to treat sickle cell disease

CRISPR/Cas9 genome editing to treat sickle cell disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Détails bibliographiques
Auteur principal: Ullah, Mohammad
Autres auteurs: Islam, Farzana
Format: Thèse
Langue:English
Publié: Brac University 2023
Sujets:
SCD
CRISPR/Cas9
Hematopoietic stem/progenitor cells
Fetal hemoglobin
Gene editing tools
Genetic engineering > Research
Gene therapy > Research
Biotechnology
Accès en ligne:http://hdl.handle.net/10361/19355

Internet

http://hdl.handle.net/10361/19355

Documents similaires